Acp-103-063
ClinicalTrials.gov NCT03325556
Research payments
$1,124,493
Through program year 2022, $1,124,493 in research payments was reported against Acp-103-063, across 199 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03325556
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2022 | Research | $212,820 | 41 |
| 2021 | Research | $667,214 | 117 |
| 2020 | Research | $244,459 | 41 |
Breakdown
Usually the institution or organisation running the study, not a person.
Only reported on some payments, and a payment can report more than one category, so these amounts overlap.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ramon Gil Port Charlotte, FL Named on 17 payments
- Nisha Chhabria West Palm Beach, FL Named on 16 payments
- Hernan Pabon Miami, FL Named on 15 payments
- Barry Cutler Pembroke Pines, FL Named on 14 payments
- Diego Rielo Pembroke Pines, FL Named on 12 payments
- Mark Hernandez Hialeah, FL Named on 12 payments
- Gary Usher Dover, NH Named on 9 payments
- Timothy Wierzbicki Port Orange, FL Named on 9 payments
- Ashok Patel Toms River, NJ Named on 9 payments
- Joel Vandersluis Dayton, OH Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.